Trelagliptin

Therapeutic Group

Blood Glucose Lowering Drugs, Excluding Insulin

Indication Dosage

Indication:
Trelagliptin is used for the treatment of type 2 diabetes mellitus to improve blood sugar control in adults, usually in combination with diet and exercise.

Dosage:

  • Adults: 100 mg once weekly, taken orally.
  • Renal Impairment: Dose adjustment may be needed in severe cases.
  • Pediatric Use: Not established.

Content

  • Tab 50mg: Trelagliptin 50mg

Pregnancy

Only If Clearly Needed

Stability

  • Dipeptidyl Peptidase-4 (DPP-4) Inhibitors

Contra Indications

  • Trelagliptin is contraindicated in patients with a history of hypersensitivity to the drug or any of its components. It should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment. Caution is advised in patients with liver disease or heart failure.

Precautions

  • Trelagliptin is contraindicated in patients with a history of hypersensitivity to the drug or any of its components. It should not be used in patients with type 1 diabetes, diabetic ketoacidosis, or severe renal impairment. Caution is advised in patients with liver disease or heart failure.

Lactation

  • Only If Necessary

Side Effects

  • Headache
  • Nausea
  • Dizziness
  • Upper respiratory tract infection
  • Hypoglycemia (when used with other antidiabetic drugs)
  • Rash
  • Increased liver enzymes

Available Brands